Vimta Labs rises after strong Q4 performance; board OKs 1:1 bonus share issue
EBITDA improved by 31.9% to Rs 34.68 crore in Q4 FY25 from Rs 26.30 crore in Q4 FY24. EBITDA margin was 36.1% in Q4 FY25 as against 36.0% in Q4 FY24.
Profit before tax in Q4 FY25 stood at Rs 25.03 crore, up by 39.5% from Rs 17.94 crore recorded in Q4 FY24. Tax outgo for the fourth quarter was Rs 6.71 crore as against Rs 3.98 crore in the same period last year.
Vimta Labs has reported 36.8% rise in net profit to Rs 66.75 crore on a 19.1% increase in total income to Rs 348.22 crore in FY25 as compared with FY24.
Total debt as of 31 March 2025 stood at Rs. 8.5 crore. Cash and cash equivalents, including bank balance, stood at Rs 32.9 crore as of 31 March 2025.
The board of Vimta Labs has granted its approval for increasing the companys borrowing powers up to Rs 300 crore, subject to approval of shareholders at the ensuing annual general meeting.
The companys board has approved a dividend of Rs 2 per equity share for the financial year 2024-25.
The board has also recommended the issue of bonus shares in the ratio of 1:1, subject to the approval of shareholders in the ensuing AGM.
Vimta Labs has announced its strategic expansion into Biologics Contract Research and Development services.
"This foray marks a significant milestone in our growth journey, reinforcing our commitment to serve the evolving needs of the biopharmaceutical industry. The new service line will focus on Novel Biologic Entities (NBEs), biosimilars, and peptide-based therapeutics using both microbial and mammalian platforms.
Capabilities will include end-to-end development from clone and process development to drug product development and biosimilarity assessment. Development lab is being set up, with requisite manpower by Q3 of FY26, and revenues are expected to commence from FY27, the company stated.
Harita Vasireddi, managing director, Vimta Labs, said: "We are pleased to report strong earnings and good growth this year, driven by growth in pharmaceutical services. Our pharma business benefited from increased traction in clinical and analytical services, supported by capacity expansion and deeper client engagements.
We are excited to announce our entry into Biologics Contract R&D services, a strategic move that aligns with the future of healthcare and enhances our capabilities across the biopharma value chain. This initiative will enable Vimta to offer end-to-end support for biologics development, reinforcing our position as a trusted partner in high-quality, science-driven innovation."
Vimta Labs is a leading contract research and testing organization, providing food, agri, bio/pharmaceutical, medical device, speciality chemical, and electronics companies an integrated scientific, technical, and regulatory expertise to support all stages of product development and manufacturing process. Vimta also provides environmental assessments and testing services.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
19 minutes ago
- News18
DMart Shares In Focus After Muted Profit Growth In Q1FY26, Should You Sell Or Buy?
Last Updated: DMart Share Price: DMart shares are in focus after Q1FY26 results reflecting a flat growth in PAT. DMart Share Price: Shares of Avenue Supermarts, the owner of popular retail franchise DMart, are in focus following the first quarter results for the financial year 2025-26. DMart reported a standalone net profit of Rs 830 crore in Q1, reflecting a marginal gain of 2 per cent year-on-year from Rs 812 crore in the corresponding quarter of the previous financial year. PAT margin also fell 5.2 per cent in Q1FY26 as compared to 5.9 per cent in Q1FY25. However, the retail operator's revenue from operations jumped 16 per cent YoY to Rs 15,932 crore. It was Rs 13,712 crore in the same period last year. Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q1FY26 stood at Rs 1,313 crore, as compared to Rs 1,221 crore in the corresponding quarter of last year. EBITDA margin stood at 8.2% in Q1FY26 as compared to 8.9% in Q1FY25. The retail operator opened 9 new stores during the quarter. The total number of stories stands at 424 as on June 30, 2025. Commenting on the performance of the company Mr. Neville Noronha, CEO & Managing Director, Avenue Supermarts, said: 'Our revenue in Q1 FY26 grew by 16.2% over the previous year. Profit after tax (PAT) grew by 2.1% over the previous year. Two years and older DMart stores grew by 7.1% during Q1 FY26 as compared to Q1 FY25. Revenue growth impact of approximately 100-150 bps was primarily due to high deflation in many staples and non-food products. Gross margins are lower as compared to the same period in the previous year, due to continued competitive intensity within the FMCG space. Operating costs are higher due to our efforts on improving service levels, capacity building and inflation at entry level wages. In the last sessions, shares of Avenue Supermarts settled at Rs 4,068 apiece, down 2.40 per cent from the previous day close at Rs 4,167.85 apiece. Disclaimer: The views and investment tips by experts in this report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions. view comments First Published: July 14, 2025, 07:07 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
36 minutes ago
- News18
Elon Musk On Warpath With Trump, But Tesla And Starlink To Make Big Bang Indian Debut
Last Updated: Elon Musk's Tesla and Starlink are both entering India this week. Tesla's first showroom opens in Mumbai while Starlink promises high-speed internet Elon Musk may now be on the warpath with US President Donald Trump, but his two major companies – Tesla and Starlink – are on the cusp of entering India. This means cutting-edge electric vehicle technology coming to India, along with the fastest satellite connectivity. This week, on Tuesday (July 15), Tesla's first showroom will open in India at Mumbai's Bandra Kurla Complex. Tesla announced its entry into India with a new X handle. The company is calling its showroom as an 'experience centre" and five Model Y vehicles are said to have landed in the city ahead of the launch. Delhi's Aerocity could have the second showroom by the end of this month. And, when can you book and get a Tesla? August or September. But be prepared to cough up a bomb – almost Rs 65 lakh to Rs 70 lakh, which is double of what the Model Y costs in the United States. Well, the reason is that Tesla cars are being directly imported so far and, hence, cannot escape the 70 percent import duty that India charges. Then there are other surcharges and registration costs. The import duty would have been 110 percent, but India reduced it to 70 percent earlier this year to enable Tesla's entry. Tesla, so far, has no plans to manufacture its EV in India – something that the Narendra Modi-led government wants Musk to do so that the cars can become affordable for Indians and also create jobs here. Tesla for now will be importing the cars. India could be the biggest EV maker in the years to come – and Tesla no longer wants to miss out on the early mover advantage. But at a price tag of Rs 65 lakh to Rs 70 lakh, Tesla is not challenging the big players in India's EV market – from Mahindra to Tata, which have far more affordable offerings. Even BYD is competitively priced. Musk's other big offering – Starlink – is also set for an Indian debut in the next few days. India officially opened its doors to Starlink last week to launch internet services. The Indian National Space Promotion and Authorisation Centre granted a nod to Starlink Satellite Communications, signalling the country's growing embrace of private space and communication technology. This will enable provisioning of the Low Earth Orbit (LEO) satellite constellation, namely Starlink Gen1, and the private company can provide satellite communication services in India for the next five years. The Starlink Gen1 Constellation is a global constellation with 4,408 satellites orbiting Earth at altitudes varying between 540 km and 570 km, capable of providing ~600 Gbps throughput over India. Again, the Starlink service will come at a higher cost than your regular broadband or WiFi service but will be much faster. Minister for Communications Jyotiraditya Scindia recently told News18 that India will be the biggest market for Satcom in the coming years. 'This (Starlink) is the third (satcom) licence being given out in India, and there are others also in queue. India is ready as a vibrant market to welcome every player into our country if they check all the boxes. Licence will be given, spectrum will be given on an administratively assigned system, price of which will be determined by regulatory authority. The market is wide open to come and service our customers," Scindia had said. view comments First Published: July 14, 2025, 07:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
India.com
36 minutes ago
- India.com
Masterstroke by Kumar Mangalam Birla, announces Rs 22000000000 for the expansion of..., to launch new AI centres at...
Kumar Mangalam Birla New Delhi: Kumar Mangalam Birla, chairman of Aditya Birla Group, has announced a major expansion plans worth Rs 2200 crore for BITS Pilani. According to the company, the main aim is to boost capacity, launch new AI centres and an edtech platform. The group will fund a new AI campus in Andhra Pradesh's Amaravati, upgrade the infrastructure at the existing campuses and launch a new edtech platform BITS Pilani Digital, CNBC-TV18 reported. quoting Birla, who is also the chancellor of the technology institution.
